DAN
Dana Incorporated
DAN has the edge over NKE overall, supported by stronger modeled upside and lower modeled downside.
NKE
NIKE, Inc.
NKE offers stronger valuation, but that advantage does not outweigh its weaker overall profile.
DAN Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Under pressure | |
| Stable |
DAN's profitability is currently healthy, and its revenue and balance sheet are stable, but its cash flow is under pressure.
NKE Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Stable | |
| Strong |
NKE's profitability and balance sheet are currently healthy, and its revenue and cash flow are stable.
DAN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 2.4x | $23.26 | — |
| Cheap | 5.9x | $56.02 | +141% |
| Forward | 6.6x | $23.26 | — |
| Fair | 16x | $152 | +553% |
| Expensive | 53x | $506 | +2075% |
Historical ranges are pointers, not guarantees.
DAN has the edge over NKE in the historical PE scenario, which offers more potential upside but is not a forecast.
NKE PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 18x | $37.76 | — |
| Cheap | 23x | $47.70 | +26% |
| Forward | 30x | $37.76 | — |
| Fair | 33x | $68.16 | +80% |
| Expensive | 47x | $97.86 | +159% |
Historical ranges are pointers, not guarantees.
NKE's PE is in its cheap range at 18x. On analysts' estimates for next year's earnings, today's price would be 30x, in its fair range.
DAN Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Strong growth | |
| Strong growth | |
| Stable | |
| Limited | |
| Low |
Analysts expect strong earnings and revenue growth for DAN, with profitability holding steady. However, they disagree widely on these estimates.
NKE Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Stable | |
| Decline | |
| Improving | |
| Moderate | |
| Low |
Analysts expect NKE's profitability to improve, but its revenue to decline. However, they disagree widely on these estimates.
DAN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $3.54 | -63% |
| Q3 2026 | $9.55 | +2022% |
| Q2 2026 | $10.05 | +$10.21 |
| Q1 2026 | $10.29 | +$10.53 |
| Q4 2025 | $0.57 | +$0.96 |
| Q3 2025 | $0.45 | +$0.56 |
| Q2 2025 | -$0.16 | -$0.15 |
| Q1 2025 | -$0.24 | -367% |
| Q4 2024 | -$0.39 | -250% |
DAN has the edge over NKE on earnings, with more consistent year-over-year improvement.
NKE Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.27 | -39% |
| Q3 2026 | $2.09 | +7.2% |
| Q2 2026 | $2.10 | -2.8% |
| Q1 2026 | $1.51 | -50% |
| Q4 2025 | $1.70 | -48% |
| Q3 2025 | $1.95 | -44% |
| Q2 2025 | $2.16 | -42% |
| Q1 2025 | $3.01 | -11% |
| Q4 2024 | $3.24 | -5.3% |
NKE's earnings per share have fallen from their peak: $2.09 over the past year, against $3.82 in late 2021.
DAN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $2B | +6.3% |
| Q2 2026 | $2B | +3.9% |
| Q1 2026 | $1.9B | -21% |
| Q4 2025 | $1.9B | -20% |
| Q3 2025 | $1.9B | -23% |
| Q2 2025 | $1.9B | -29% |
| Q1 2025 | $2.4B | -14% |
| Q4 2024 | $2.3B | -6.4% |
DAN's revenue is recovering but still below its 2023 peak: $2B last quarter, up 6.3% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 4.5% | +1.8 points |
| Q2 2026 | 3.8% | +2.9 points |
| Q1 2026 | 1% | -2 points |
| Q4 2025 | 3.3% | +4.9 points |
| Q3 2025 | 2.8% | -0.8 points |
| Q2 2025 | 0.8% | -3 points |
| Q1 2025 | 3.1% | +0.5 points |
| Q4 2024 | -1.5% | -2 points |
DAN's operating margin was 4.5% last quarter, up 1.8 points from the same quarter a year ago.
NKE Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $11.2B | -4.3% |
| Q2 2026 | $11B | -1.1% |
| Q1 2026 | $11.3B | +0.1% |
| Q4 2025 | $12.4B | +0.6% |
| Q3 2025 | $11.7B | +1.1% |
| Q2 2025 | $11.1B | -12% |
| Q1 2025 | $11.3B | -9.3% |
| Q4 2024 | $12.4B | -7.7% |
NKE has the edge over DAN on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 8.2% | +0.3 points |
| Q2 2026 | 12% | +9.2 points |
| Q1 2026 | 5.8% | -1.7 points |
| Q4 2025 | 8% | -3.4 points |
| Q3 2025 | 7.9% | -3.4 points |
| Q2 2025 | 2.9% | -11 points |
| Q1 2025 | 7.5% | -3.8 points |
| Q4 2024 | 11% | -2.9 points |
NKE has the edge over DAN on profitability, with a higher operating margin.
DAN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $32M | -48% |
| Q2 2026 | -$33M | -1200% |
| Q1 2026 | -$257M | -$145M |
| Q4 2025 | $345M | +132% |
| Q3 2025 | $62M | +$73M |
| Q2 2025 | $3M | -97% |
| Q1 2025 | -$112M | +$60M |
| Q4 2024 | $149M | +9.6% |
DAN has the edge over NKE on cash flow, with more consistent year-over-year improvement.
NKE Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$64M | -527% |
| Q2 2026 | $1.5B | +313% |
| Q1 2026 | $284M | -83% |
| Q4 2025 | $386M | -58% |
| Q3 2025 | $15M | -95% |
| Q2 2025 | $363M | -85% |
| Q1 2025 | $1.7B | -11% |
| Q4 2024 | $920M | -65% |
NKE usually generates cash, though not every quarter: the latest was −$64M, but it generated $2.1B over the past year.
DAN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -3.7% | -4M shares |
| 1 year | -19% | -25.3M shares |
| 3 years | -27% | -39.2M shares |
| 5 years | -28% | -40.7M shares |
| Available history | -27% | -39.6M shares |
DAN has the edge over NKE on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $200M |
| Q2 2026 | $44M |
| Q1 2026 | $125M |
| Q4 2025 | $211M |
| Q3 2025 | $182M |
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | — |
DAN spent $580M buying back its own shares over the past year.
NKE Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +3.2M shares |
| 1 year | +0.4% | +5.2M shares |
| 3 years | -3.8% | -59.1M shares |
| 5 years | -8.4% | -135M shares |
| Available history | -6.9% | -110M shares |
NKE has 1.5B diluted shares, about the same as a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | $20M |
| Q3 2025 | $126M |
| Q2 2025 | $199M |
| Q1 2025 | $506M |
| Q4 2024 | $1.1B |
NKE has spent almost nothing on buybacks in the past year.
DAN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 2.1x | Moderate |
| Q2 2026 | 1.8x | Healthy |
| Q1 2026 | 1.5x | Healthy |
| Q4 2025 | 4.8x | High |
| Q3 2025 | 5.7x | High |
| Q2 2025 | 4.9x | High |
| Q1 2025 | 3.5x | Elevated |
| Q4 2024 | 3.3x | Elevated |
DAN's net debt is about 2.1 years of its operating earnings (EBITDA), down from 5.7 years a year ago.
NKE Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.2x | Very low |
| Q2 2026 | 0.1x | Very low |
| Q1 2025 | 0.1x | Very low |
| Q4 2024 | 0.2x | Very low |
| Q3 2024 | 0.1x | Very low |
| Q2 2024 | -0.1x | Net Cash |
| Q1 2024 | -0.0x | Very low |
| Q4 2023 | 0.1x | Very low |
NKE has the edge over DAN on leverage, with a lower net debt burden relative to earnings.
DAN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 38.5 | Neutral |
| Stochastic | 7.3 | Oversold |
DAN's weekly RSI is 39 (neutral) and its Stochastic is 7 (oversold).
NKE Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 40.0 | Neutral |
| Stochastic | 57.5 | Neutral |
NKE's weekly RSI is 40 (neutral) and its Stochastic is 58 (neutral).
DAN PE vs Consumer Cyclical Sector
| Metric | DAN | Sector median | Relative |
|---|---|---|---|
| PE | 2.4x | 18x | 86% below |
| PE % | 2 | 47 | 45 pts below |
DAN has the edge over NKE on valuation relative to its sector.
NKE PE vs Consumer Cyclical Sector
| Metric | NKE | Sector median | Relative |
|---|---|---|---|
| PE | 18x | 18x | 0.3% above |
| PE % | 2 | 47 | 45 pts below |
NKE is trading at 18x earnings, in line with the Consumer Cyclical sector's median of 18x.
DAN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $26.0 | 11% below |
| 20 week MA | $27.7 | 16% below |
| 50 week MA | $29.8 | 22% below |
| 100 week MA | $23.2 | 0.4% above |
| 200 week MA | $18.3 | 27% above |
DAN has the edge over NKE on trend strength, trading above more of its moving averages.
NKE Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $36.7 | 2.8% above |
| 20 week MA | $39.2 | 3.6% below |
| 50 week MA | $48.0 | 21% below |
| 100 week MA | $58.4 | 35% below |
| 200 week MA | $79.2 | 52% below |
NKE has bounced recently, but its long-term trend is still down: it's above its 8-week average, but 52% below its 200-week average.
DAN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $18.4 | $19.6 | +6.7% |
| 2021 | $19.6 | $22.5 | +15% |
| 2022 | $22.5 | $14.9 | -34% |
| 2023 | $14.9 | $14.6 | -2.1% |
| 2024 | $14.6 | $11.7 | -20% |
| 2025 | $11.7 | $23.9 | +104% |
| 2026 YTD | $23.9 | $23.3 | -2.6% |
DAN has the edge over NKE on returns for 2026, with the stronger performance.
NKE Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $101.6 | $141.6 | +39% |
| 2021 | $141.6 | $165.7 | +17% |
| 2022 | $165.7 | $116.3 | -30% |
| 2023 | $116.3 | $108.6 | -6.6% |
| 2024 | $108.6 | $76.4 | -30% |
| 2025 | $76.4 | $60.9 | -20% |
| 2026 YTD | $60.9 | $37.8 | -38% |
NKE has finished four years in a row lower, and it's down 38% so far in 2026.